Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Tokyo  >  Itochu Corp    8001   JP3143600009

Mes dernières consult.
Most popular
News SummaryMost relevantAll newsSector newsTweets

Itochu Corp : ITOCHU Announces Collaboration with AIR WATER INC. in the Healthcare Field

share with twitter share with LinkedIn share with facebook
share via e-mail
02/14/2013 | 07:43am CEST

Primary contents from here.

February 14, 2013

ITOCHU Corporation (headquartered in Minato-ku, Tokyo; Masahiro Okafuji, President & CEO; hereinafter "ITOCHU") announced today that it has agreed to transfer 60% of the shares of ITOCHU's wholly owned subsidiary, Healthcare-Tech Corporation (headquartered in Fuchu City, Tokyo; Kenichi Watanabe, President; hereinafter "Healthcare-Tech"), to AIR WATER INC. (headquartered in Osaka City, Osaka; Hiroshi Aoki Chairman & CEO; hereinafter "AIR WATER"). The shares will be transferred following the necessary approval of the relevant authorities.

Healthcare-Tech possesses know-how and a proven track record from 20 years' experience as one of the leading Supply Processing Distribution (hereinafter "SPD services") companies specializing in medical equipment and pharmaceuticals. The company has been steadily increasing its contract business, mainly for large hospitals in Japan. Healthcare-Tech also provides a range of services to medical organizations, including wholesale of generic pharmaceuticals and import and sales of medical equipment.

AIR WATER is one of the major suppliers of medical gas and hospital facility constructors in Japan. The company provides a wide range of total healthcare services to a number of domestic medical organizations, including SPD Services, contract sterilization services, manufacturing and sales of medical equipment, nursing care services and home medical care services. ITOCHU resolved to transfer part of its share of Healthcare-Tech, recognizing collaboration with AIR WATER in SPD Services as the best opportunity to accelerate the growth of Healthcare-Tech.

In a joint effort with AIR WATER, ITOCHU will continue to improve the corporate value of Healthcare-Tech and to create a new business model of high value, taking advantage of the know-how it has accumulated during its many years in the medical industry, and its procurement ability based on its domestic and international networks.

distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on ITOCHU CORP
10/09 ITOCHU : Mr. and Mrs. Robert (Doris) Harper
10/04 ITOCHU : Reclamation Awards $21.7 Million Contract to Refurbish Pump Generating ..
09/27 ITOCHU : Global Light Towers Market 2017- Hangzhou Mobow, JCB, Wacker Neuson, Al..
09/27 ITOCHU CORP : ex-dividend day for interim dividend
09/21 ACG extension to contribute to future development of Azerbaijan-Japan relatio..
09/19 SOCAR - The Azerbaijan Government and co venturers sign amended and restated ..
09/19 Ovl, partners to pay $3.6 billion to extend azerbaijan output
09/16 The New Era Begins in the Oil Industry in Azerbaijan
09/16 Azerbaijan, co-venturers sign amended PSA for Azeri, Chirag and deepwater Gun..
09/16 Azerbaijan, co-venturers sign amended PSA for Azeri, Chirag and deepwater Gun..
More news
News from SeekingAlpha
08/28 NIKKEI : Japanese firms form $457M fund for start-ups
08/05 Itochu Corp. ADR reports Q1 results
04/20 Geothermal Power - Ormat Technologies, Toshiba And ENGIE Have Major Projects ..
02/07 Itochu Corp. ADR 2017 Q3 - Results - Earnings Call Slides
2015 Itochu Management's Unrealistic Goals Look Like A Real Obstacle
Financials ( JPY)
Sales 2018 5 246 B
EBIT 2018 -
Net income 2018 409 B
Debt 2018 2 320 B
Yield 2018 3,48%
P/E ratio 2018 7,16
P/E ratio 2019 7,18
EV / Sales 2018 1,04x
EV / Sales 2019 0,98x
Capitalization 3 136 B
Duration : Period :
Itochu Corp Technical Analysis Chart | 8001 | JP3143600009 | 4-Traders
Technical analysis trends ITOCHU CORP
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 12
Average target price 1 994  JPY
Spread / Average Target 5,7%
EPS Revisions
Masahiro Okafuji President, Chief Executive Officer & Director
Eizo Kobayashi Chairman
Hiroyuki Kaizuka Executive Officer & Manager-Operations
Tsuyoshi Hachimura Chief Financial Officer & Representative Director
Hitoshi Okamoto Director, Chief Strategy & Information Officer
Sector and Competitors
1st jan.Capitalization (M$)
ITOCHU CORP21.56%27 621
MITSUI & CO LTD3.05%26 185
SAMSUNG C&T CORP--.--%24 605
SUMITOMO CORP15.89%17 556